Sickle cell disease: open trials in Netherlands

7 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT07224360
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Trial Treatment · Phase 2 · CSL Behring
Amsterdam UMC Stichting, Amsterdam
Registry updated 2026-11-03
NCT06975865
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Trial Treatment · Phase 3 · Sanofi
Rotterdam
Registry updated 2026-10-15
NCT06699849
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Trial Treatment · Phase 2 · CSL Behring
Amsterdam UMC Stichting, Amsterdam · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-10-08
2025-524464-38-00
A research study to evaluate how well etavopivat works in children with sickle cell disease
Trial Treatment · Phase 3 · Novo Nordisk A/S
Amsterdam UMC Stichting, Amsterdam
Registry updated 2026-09-28
NCT06612268
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Trial Treatment · Phase 3 · Novo Nordisk A/S
Amsterdam UMC Stichting, Amsterdam · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Haga Hospital, 's-Gravenhage · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-09-17
2024-513528-41-02
The Effect of Mitapivat on Cerebral Perfusion and Oxygen Metabolism in Sickle Cell Disease
Trial Treatment · Phase 3 · Amsterdam UMC Stichting
Amsterdam UMC Stichting, Amsterdam
Registry updated 2026-05-08
NCT07001631
Effect of EMDR for Reduction of Pain Interference in Children With Sickle Cell Disease
Trial Treatment · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Amsterdam UMC, Amsterdam
Registry updated 2025-06-03

All Sickle cell disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Sickle cell disease: open trials in Netherlands

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

A research study to evaluate how well etavopivat works in children with sickle cell disease

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

The Effect of Mitapivat on Cerebral Perfusion and Oxygen Metabolism in Sickle Cell Disease

Effect of EMDR for Reduction of Pain Interference in Children With Sickle Cell Disease